Quantum X Labs names Yakov Baranes co-CEO

Quantum X Labs Inc. appointed Yakov Baranes as co-Chief Executive Officer, effective May 18, 2026, alongside existing CEO Amihay Hadad, who will continue in a co-CEO structure.

Rhea-AI Filing Summary

Quantum X Labs Inc. appointed Yakov Baranes as co-Chief Executive Officer, effective May 18, 2026, alongside existing CEO Amihay Hadad, who will continue in a co-CEO structure. Baranes has 11 years of strategy experience across industries and government entities and has led Quantum X Labs Ltd., the company’s Israeli quantum-focused subsidiary, since March 2025.

Under a new agreement effective June 1, 2026, Baranes will receive a base salary of NIS 36,000 + VAT per month as co-CEO, plus NIS 24,000 + VAT per month for services to Quantum Israel, with eligibility for board-determined bonuses. The agreement is open-ended with a 60-day termination notice by either party, and immediate termination for cause is permitted.

In the March 2026 acquisition of Quantum Israel, Baranes, who previously held 32,647 shares (approximately 5.54%) of Quantum Israel, received 103,373 shares of common stock and pre-funded warrants to purchase 246,387 shares of Quantum X Labs common stock and may receive up to an additional 703,710 shares or pre-funded warrants upon achieving specified milestones.

Insights

Corporate governance analyst

Quantum X Labs adds a co-CEO with incentive-heavy equity ties to its quantum Israel unit.

The company is moving to a co-CEO model by adding Yakov Baranes alongside long-time CEO Amihay Hadad. Baranes already leads the Israeli quantum subsidiary and brings 11 years of strategy work with companies and government bodies, aligning leadership with that unit’s growth.

Compensation combines a modest NIS-based salary with significant existing and potential equity, including pre-funded warrants and milestone-based share grants. This structure links Baranes’ upside to execution at Quantum Israel, while the open-ended agreement with 60-day notice gives the board flexibility if the co-CEO model proves less effective.

8-K Event Classification

2 items: 5.02, 9.01

2 items

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

Key Figures

Co-CEO base salary: NIS 36,000 + VAT per month Quantum Israel services fee: NIS 24,000 + VAT per month Prior Quantum Israel stake: 32,647 shares (5.54%) +5 more

8 metrics

Co-CEO base salary NIS 36,000 + VAT per month Compensation for serving as co-Chief Executive Officer, effective June 1, 2026

Quantum Israel services fee NIS 24,000 + VAT per month Ongoing payments for services provided to Quantum Israel

Prior Quantum Israel stake 32,647 shares (5.54%) Baranes’ holdings in Quantum Israel before its acquisition

Shares received in acquisition 103,373 common shares Quantum X Labs common stock issued to Baranes in Quantum Israel deal

Pre-funded warrants received 246,387 shares underlying Pre-funded warrants to purchase Quantum X Labs common stock

Additional milestone equity Up to 703,710 shares or warrants Contingent on achievement of specified milestones post-acquisition

Co-CEO effective date May 18, 2026 Start date for Baranes as co-Chief Executive Officer

Agreement effective date June 1, 2026 Start date of the Baranes Agreement terms

Key Terms

pre-funded warrants, Item 5.02, Regulation S-K, emerging growth company, +2 more

6 terms

pre-funded warrants financial

"received 103,373 shares of common stock and pre-funded warrants to purchase 246,387 shares"

Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.

Item 5.02 regulatory

"Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers"

Regulation S-K regulatory

"required to be disclosed pursuant to Item 404(a) of Regulation S-K"

A set of U.S. Securities and Exchange Commission rules that tell public companies which narrative and qualitative details must be disclosed in filings, such as risk factors, management discussion, executive pay, legal proceedings and business description. Think of it as a standardized checklist or blueprint that ensures investors get the same types of background information from every company so they can compare risks, management quality and strategy before making investment decisions.

emerging growth company regulatory

"Emerging growth company"

An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.

wholly owned subsidiary financial

"Quantum X Labs Ltd. (“Quantum Israel”), the Company’s wholly owned subsidiary"

A wholly owned subsidiary is a company whose entire ownership is held by another company (the parent), so the parent controls decisions, operations, and finances. Think of it as a fully controlled branch that runs as its own legal entity but whose results flow straight into the parent’s financial statements; investors watch these structures because they affect consolidated revenue, risk exposure, and how profits, liabilities, and cash flow are allocated across the corporate group.

co-Chief Executive Officer financial

"appointed Mr. Yakov Baranes as the co-Chief Executive Officer of the Company"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What leadership change did Quantum X Labs (QXL) disclose in this 8-K?

Quantum X Labs appointed Yakov Baranes as co-Chief Executive Officer, effective May 18, 2026, joining existing CEO Amihay Hadad in a co-CEO structure. Hadad remains in place, and both will share top executive responsibilities going forward.

What is Yakov Baranes’ compensation as co-CEO of Quantum X Labs (QXL)?

Baranes will receive NIS 36,000 plus VAT per month as base salary for serving as co-CEO and NIS 24,000 plus VAT per month for services to Quantum Israel. He is also eligible for discretionary bonuses determined by the board of directors.

How is Yakov Baranes’ agreement with Quantum X Labs (QXL) structured?

The Baranes Agreement takes effect June 1, 2026 and continues until either party gives at least 60 days’ written notice. The company may terminate his service without prior notice for cause, providing flexibility while formalizing his co-CEO role and compensation.

What equity did Yakov Baranes receive through Quantum X Labs’ (QXL) acquisition of Quantum Israel?

In the Quantum Israel acquisition, Baranes received 103,373 Quantum X Labs common shares and pre-funded warrants to purchase 246,387 shares. He may receive up to an additional 703,710 shares or pre-funded warrants if specified milestones are achieved after the transaction.

What was Yakov Baranes’ ownership in Quantum Israel before Quantum X Labs (QXL) acquired it?

Before the acquisition, Baranes held 32,647 Quantum Israel shares, representing approximately 5.54% of that company. This prior stake underpins the equity consideration he received in Quantum X Labs when Quantum Israel became a wholly owned subsidiary.

What business focus does Quantum Israel have within Quantum X Labs (QXL)?

Quantum Israel aims to research, develop, and potentially commercialize quantum solutions in navigation, precision timing, quantum algorithms, error correction, drug discovery, biomedicine, nuclear simulation, transportation, and quantum cyber security, positioning Quantum X Labs in multiple advanced quantum technology sectors.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/15/2026 - 04:30 PM Learn about SEC filing dates

false 0000797542 0000797542 2026-05-14 2026-05-14 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of report (date of earliest event reported): May 14, 2026

QUANTUM X LABS INC.

(Exact Name of Registrant as Specified in its Charter)

Commission File No.: 001-42681

Delaware		68-0080601
(State of Incorporation)		(I.R.S. Employer Identification No.)

2 Jabotinsky St, Atrium Tower, 18th floor Ramat Gan, Israel 5252903		6971068
(Address of Registrant’s Office)		(ZIP Code)

Registrant’s Telephone Number, including area code: +972 9-774-1505

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.0001 per share		QXL		The Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On May 14, 2026, Quantum X Labs Inc. (the “Company”) appointed Mr. Yakov Baranes as the co-Chief Executive Officer of the Company, effective as of May 18, 2026, joining Mr. Amihay Hadad, who has served as the Company’s Chief Executive Officer since February 2020 and will continue with Mr. Baranes as co-Chief Executive Officer.

Yakov Baranes is a business strategy expert with a demonstrated 11 year history of working with various industries and government entities. Since March 2025, Mr. Baranes has led the initial activities of Quantum X Labs Ltd. (“Quantum Israel”), the Company’s wholly owned subsidiary, that was acquired by the Company in March 2026, that aims to position the Company as a leading company to research, develop, and potentially commercialize innovative quantum solutions across key sectors, including navigation, precision timing, quantum algorithms, quantum error correction, drug discovery, biomedicine, nuclear simulation, transportation, and quantum cyber security. Mr. Baranes has also served as a member of the board of directors of Charging Robotics Inc. (OTC: CHEV) since April 2023 and previously served as its chief executive officer from September 2025 to April 2026. Mr. Baranes is skilled in business strategy planning and implementations on a corporate level and business unit level and has also worked with start-up companies in shaping their business plans and supporting their capital raising rounds. Mr. Baranes holds a Bachelor of Arts (B.A.) in Economics from the Technion - Israel Institute of Technology and a MBA from IDC, Herzliya.

In connection with the appointment of Mr. Baranes, the Company will enter into an agreement with Mr. Baranes (the “Baranes Agreement”) pursuant to which Mr. Baranes will serve as the Company’s co-Chief Executive Officer. Pursuant to the terms of the Baranes Agreement, Mr. Baranes will receive NIS 36,000 + VAT per month as his base salary to serve as the Company’s co-Chief Executive Officer, plus NIS 24,000 + VAT that Mr. Baranes currently receives through services that he provides to Quantum Israel. Mr. Baranes shall be eligible to receive such bonus as determined by the Company’s board of directors. The terms of the Baranes Agreement shall be effective as of June 1, 2026, and shall continue until such time either party provides written notice to the other party at least 60 days in advance of the termination of such agreement. The Company may also terminate Mr. Baranes’ service to the Company without prior written notice for cause.

There is no arrangement or understanding between Mr. Baranes and any other persons pursuant to which Mr. Baranes was appointed as co-Chief Executive Officer. In addition, other than securities received in connection with the Company’s acquisition of Quantum Israel, Mr. Baranes is not a party to any transaction, or series of transactions, required to be disclosed pursuant to Item 404(a) of Regulation S-K. Mr. Baranes was a shareholder of Quantum Israel and held 32,647 shares (approximately 5.54%) of Quantum Israel prior to the Company’s acquisition of Quantum Israel. In connection with the Company’s acquisition of Quantum Israel, Mr. Baranes received 103,373 shares of common stock and pre-funded warrants to purchase 246,387 shares of the Company common stock. Mr. Baranes may receive up to an additional 703,710 shares of common stock or pre-funded warrants upon the achievement of certain milestones.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.		Description
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Quantum X Labs Inc.
By:	/s/ Amihay Hadad
Name:	Amihay Hadad
Title:	Chief Executive Officer

Date: May 15, 2026

Filing Exhibits & Attachments

3 documents

Other Documents

• EX-101 XBRL SCHEMA FILE 2.9 KB
• EX-101 XBRL LABEL FILE 33.4 KB
• EX-101 XBRL PRESENTATION FILE 21.8 KB